期刊文献+

维生素D联合二甲双胍对多囊卵巢综合征患者排卵及子宫内膜容受性的影响研究 被引量:10

Effect of vitamin D in combination with metformin in treatment of patients with PCOS ovulation and the receptivity of endometrium
下载PDF
导出
摘要 目的探究维生素D联合二甲双胍对多囊卵巢综合征患者排卵及子宫内膜容受性的影响。方法选取某院妇科收治的多囊卵巢综合征108例,采用双盲随机分为两组。对照组52例,患者口服二甲双胍500 mg,3次/d,4周为一个疗程;观察组56例,在口服二甲双胍的基础上用维生素D,口服1200 IU/d,4周为一个疗程。一个疗程结束后,对两组患者排卵、子宫内膜容受性等情况进行比较分析。结果 1治疗后,观察组排卵周期数、排卵例数及总排卵率(25、18、32.14%)显著高于对照组(13、6、11.53%),差异有统计学意义(P<0.05);2治疗后,两组患者子宫内膜厚度均有所减小,且观察组(6.29±2.71、82.19%)显著优于对照组(7.69±2.53、89.32%),差异有统计学意义(P<0.05),两组患者子宫内膜多层率均有所下降,且观察组显著低于对照组,差异有统计学意义(P<0.05);3治疗后,两组患者子宫内膜血流量有所下降,且观察组(60.23%)显著低于对照组(88.91%),差异有统计学意义(P<0.05);4治疗后,观察组患者Salle评分13.27分显著低于对照组17.52分,差异有统计学意义(P<0.05)。结论维生素D联合二甲双胍可有效提高患者排卵率、减少子宫内膜增厚、减轻子宫多层率、改善子宫血管血流量,是治疗多囊卵巢综合征患者的有效药物,值得临床推广。 Objective To explore the effect of vitamin D in combination with metformin ovulation in treatment of patients with polycystic ovary syndrome(PCOS) and the receptivity of endometrium.Methods 108 cases of patients with polycystic ovary syndrome treated in department of gynaecology,were randomly divided into two groups by double blinding.52 cases were treated with routine western medicine,with oral metformin 500 mg / d,taking three times,four weeks for a period of treatment.Experimental group with 56 cases,on the basis of conventional western medicine treatment with vitamin D,oral 1200 IU / d,four weeks for a period of treatment.After a period of treatment,two groups of patients with ovulation,carry on comparative analysis to the receptivity of endometrium.Results 1After treatment,patients in the experimental group with ovulation cycle number,ovulation occurring and total ovulation rate(25,18,32.14%) was significantly higher than that of control group(13,6,11.53%),the difference was statistically significant(P〈0.05).2Two groups of patients with endometrial thickness is reduced after treatment,and the experimental group(6.29 ± 2.71,82.19%) was significantly better than the control group(7.69 ± 2.53,89.32%),the difference was statistically significant(P〈0.05).Two groups of patients with endometrial multilayer rate were decreased.The experimental group was significantly lower than the control group,the difference was statistically significant(P〈0.05).3After treatment,two groups of patients with endometrial blood flow rate were decreased,and the experimental group(60.23%) was significantly lower than the control group(88.91%),the difference was statistically significant(P〈0.05).4Two groups of patients after total effective salle grading comparison:after treatment,the experimental group(13.27) in patients with salle score was significantly lower than the control group(17.52),the difference was statistically significant(P〈0.05).Conclusion Vitamin D in combination with metformin cocoa effectively increase ovulation rate,reduce the patients with endometrial thickening,reduce multilayer rate,improve and vascular blood flow,the uterus is an effective drug for treatment of patients with polycystic ovary syndrome,and is worth clinical popularizing widely.
机构地区 解放军
出处 《东南国防医药》 2015年第2期142-145,共4页 Military Medical Journal of Southeast China
关键词 维生素D 二甲双胍 联合用药 多囊卵巢综合征 排卵 内膜容受性 vitamin D metformin combination polycystic ovary syndrome ovulation lining receptive
  • 相关文献

参考文献20

二级参考文献97

  • 1张翠莲,高航云,赵志刚,贾萍.罗格列酮和二甲双胍治疗胰岛素抵抗多囊卵巢综合征的临床研究[J].中国实用妇科与产科杂志,2004,20(8):477-479. 被引量:26
  • 2姚均迪.生殖医学中阴道超声评估子宫内膜变化[J].国外医学(妇产科学分册),1994,21(3):135-138. 被引量:2
  • 3陈子江,赵君利,周凤荣,李媛,赵力新,马增香.济南市汉族育龄妇女PCOS患病状况的初步调查[J].现代妇产科进展,2005,14(6):442-444. 被引量:41
  • 4Jerome Strauss,吴效科.多囊卵巢综合征可能是原发性卵泡病[J].医学研究生学报,2006,19(11):1040-1043. 被引量:13
  • 5Yen SSC.生殖内分泌学(第4版)[M].北京:科学出版社,2001,3..
  • 6Knochenhauer T, Key J, Kahsar-miller M, et al. Prevalence of the polycystic ovary syndrome in uncelected black and white women of the southeastern United States: a prospective study [J] . J Clin Endocrinal, 1998, 83:3078 - 3082.
  • 7Asuncion M, Calvo RM, San Millan JL, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain [ J ] . J Clin Endocrinol Metab, 2000, 85 : 2434 - 2438.
  • 8Dunaif A, Given JR, Haseltine F, et al. The polycystic ovary syndrome, Black well Scientific [ M ] . Cambridge, MA, 1992.
  • 9Carmina E. Genetic and environmental aspect of polycystic ovary syndrome [ J ] . J Endocrinol Invest, 2003, 26 :1151 - 1159.
  • 10Eggers S, Kirchengast S. The polycystic ovary syndrome-a medical condition but also an important psychosocial problem [J] . Coll Antropol, 2001, 25:673-685.

共引文献102

同被引文献75

引证文献10

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部